Journal of Hematology, ISSN 1927-1212 print, 1927-1220 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Hematol and Elmer Press Inc
Journal website http://www.thejh.org

Case Report

Volume 6, Number 1, March 2017, pages 29-31


Multiple Myeloma-Induced Hyperammonemic Encephalopathy

Table

Table 1. Published Treatment Regimens and Outcomes for MM-Induced Hyperammonemic Encephalopathy
 
TreatmentOutcome
Bortezomib + cyclophosphamide + dexamethasone [11]Patient released home after 11 days.
Bortezomib + high dose dexamethasone + bendamustine [6]Patient died 2 weeks after treatment due to aspiration pneumonia.
Simultaneous continuous venovenous hemodialysis and extended daily hemodialysis
Vincristine + high dose dexamethasone [12]
Patient with medically refractory hyperammonemia survived and was discharged home.